Showing results (131-140 of 6,496) with videos related to
Sort By:
Pageof 650
Human Vaccines & Immunotherapeutics|August 31, 2017
Impact of a website based educational program for increasing vaccination coverage among adolescentsSusanna Esposito, Sonia Bianchini, Claudia Tagliabue, et al.Human Vaccines & Immunotherapeutics|September 1, 2017
Is seasonal vaccination a contributing factor to the selection of influenza epidemic variants?Yong Chong, Hideyuki IkematsuHuman Vaccines & Immunotherapeutics|July 9, 2016
Moving forward with human papillomavirus immunotherapiesNicolas Çuburu, John T SchillerHuman Vaccines & Immunotherapeutics|July 9, 2016
European policies on tuberculosis prevention in healthcare workers: Which role for BCG? A systematic reviewMarco Bo, Carla Maria ZottiHuman Vaccines & Immunotherapeutics|September 8, 2017
Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in adults 50 to 65 years of age in India: An open-label trialBhagirath B Solanki, Christine Juergens, Manojkumar B Chopada, et al.Human Vaccines & Immunotherapeutics|September 8, 2017
Effect of combination vaccines on completion and compliance of childhood vaccinations in the United StatesSamantha K Kurosky, Keith L Davis, Girishanthy KrishnarajahHuman Vaccines & Immunotherapeutics|April 23, 2016
Phosphate substitution in an AlOOH - TLR4 adjuvant system (SPA08) modulates the immunogenicity of Serovar E MOMP from Chlamydia trachomatisLucian Visan, Violette Sanchez, Margaux Kania, et al.Human Vaccines & Immunotherapeutics|May 10, 2016
Mucosal adjuvants: Opportunities and challengesLingbin ZengHuman Vaccines & Immunotherapeutics|May 10, 2016
Immunogenicity and safety of subunit plague vaccine: A randomized phase 2a clinical trialKai Chu, Jialei Hu, Fanyue Meng, et al.Human Vaccines & Immunotherapeutics|May 10, 2016
The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countriesN Howard, S Mounier-Jack, K E Gallagher, et al.Pageof 650